| Serial Number | 88319658 |
| Word Mark | RETHYMIC |
| Filing Date | Thursday, February 28, 2019 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, April 7, 2020 |
| Registration Number | 6026670 |
| Registration Date | Tuesday, April 7, 2020 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, January 21, 2020 |
| Goods and Services | Pharmaceutical preparations for human use for the treatment of pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto; pharmaceutical preparations for human use, namely, tissue-based regenerative therapy to treat pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto; biologic preparations for medical and therapeutic purposes for the treatment of pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto; biologic preparations for medical and therapeutic purposes, namely, tissue-based regenerative therapy to treat pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, March 19, 2019 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Enzyvant Therapeutics GmbH |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | Basel 4051 CH |
| Party Name | Enzyvant Therapeutics GmbH |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Basel 4051 CH |
| Party Name | Enzyvant Therapeutics GmbH |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Basel 4051 CH |
| Event Date | Event Description |
| Tuesday, March 19, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, March 4, 2019 | NEW APPLICATION ENTERED |
| Thursday, May 9, 2019 | ASSIGNED TO EXAMINER |
| Sunday, May 19, 2019 | NON-FINAL ACTION WRITTEN |
| Sunday, December 1, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Sunday, May 19, 2019 | NON-FINAL ACTION E-MAILED |
| Sunday, May 19, 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, July 25, 2019 | ASSIGNED TO EXAMINER |
| Saturday, November 9, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Saturday, November 9, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, November 11, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, December 4, 2019 | ASSIGNED TO LIE |
| Friday, December 6, 2019 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
| Friday, December 13, 2019 | ELECTRONIC RECORD REVIEW COMPLETE |
| Wednesday, January 1, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, January 21, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, April 7, 2020 | REGISTERED-PRINCIPAL REGISTER |
| Monday, April 7, 2025 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Tuesday, January 21, 2020 | PUBLISHED FOR OPPOSITION |